(Q34007167)

30 July 2017

1 reference

title

Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures (English)

1 reference

30 July 2017

Camilleri M

1

1 reference

PubMed ID

10947488

30 July 2017

Williams DE

series ordinal

2

1 reference

30 July 2017

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

17

1 reference

30 July 2017

4

1 reference

30 July 2017

331-338

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200017040-00003

30 July 2017

0 references

cites work

Clinical management of intractable constipation

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200017040-00003

Diagnosing and treating patients with refractory functional gastrointestinal disorders

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200017040-00003

The irritable bowel syndrome: mechanisms and a practical approach to management

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200017040-00003

Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study

21 January 2018

1 reference

12 December 2020

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure

1 reference

12 December 2020

Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Relation to gynecologic features and outcome

1 reference

12 December 2020

Irritable bowel syndrome and chronic pelvic pain.

1 reference

12 December 2020

Is rectal biopsy necessary in irritable bowel syndrome?

1 reference

12 December 2020

Irritable bowel syndrome. Diagnosis in the managed care era.

1 reference

12 December 2020

Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates

1 reference

12 December 2020

Validation of a specific quality of life questionnaire for functional digestive disorders

1 reference

12 December 2020

Functional digestive disorders (FDD) in the year 2000--economic impact.

1 reference

12 December 2020

Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome?

1 reference

12 December 2020

Review article: drug development in gastroenterology--the changing view of industry

1 reference

12 December 2020

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

1 reference

12 December 2020

Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.

1 reference

12 December 2020

Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans

1 reference

12 December 2020

Clinical economics review: irritable bowel syndrome.

1 reference

12 December 2020

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

12 December 2020

Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer.

1 reference

12 December 2020

Colorectal cancer screening: clinical guidelines and rationale

1 reference

12 December 2020

Audit of constipation in a tertiary referral gastroenterology practice.

1 reference

12 December 2020

Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms

1 reference

12 December 2020

Irritable bowel syndrome: the view from general practice.

1 reference

12 December 2020

Irritable bowel syndrome: a technical review for practice guideline development

1 reference

12 December 2020

Survey of the AGA membership relating to patients with functional gastrointestinal disorders

1 reference

12 December 2020

Successful practice in a managed care environment: managing costs while managing care

1 reference

12 December 2020

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

1 reference

12 December 2020

Screening guidelines for colorectal cancer

1 reference

12 December 2020

Medical costs in community subjects with irritable bowel syndrome

1 reference

12 December 2020

Towards positive diagnosis of the irritable bowel

1 reference

12 December 2020

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

1 reference

12 December 2020

10.2165/00019053-200017040-00003

Identifiers

DOI

1 reference

PubMed ID

10947488

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10947488